Directory
>
Shingai Majuru
Shingai Majuru
Vice President, Head of CMC, Small Molecule Development | Roivant Sciences
United States
Shingai Majuru
Summary
Shingai Majuru is a seasoned pharmaceutical development executive with extensive experience in Chemistry, Manufacturing and Controls (CMC) within the biopharmaceutical sector. He currently serves as the Vice President and Head of CMC for Small Molecule Development at Roivant Sciences, where he leads strategic evaluations and global development strategies for in-licensing opportunities. His expertise encompasses a broad spectrum of CMC activities, including formulation development, regulatory documentation, and technology transfer. Shingai has a strong academic background, holding advanced degrees in Pharmaceutics and Business. He has contributed to numerous publications in the field, reflecting his commitment to advancing pharmaceutical sciences. His leadership style is characterized by a hands-on approach, fostering teamwork and innovation. Shingai's diverse experience spans both startup and corporate environments, allowing him to navigate complex challenges in drug development effectively.
Shingai Majuru
Work Experience
Vice President, Head of CMC, Small Molecule Development at
Roivant Sciences
August 2017 - Present
Head of CMC, Drug Product Development at
ROIVANT SCIENCES LTD.
July 2018 - April 2021
Senior Director, Drug Formulation Development at
ROIVANT SCIENCES LTD.
August 2017 - July 2018
Independent Consultant at
Jsm Pharmaceutical Consulting, LLC
January 2012 - August 2017
Executive Director, Oral Products Development at
Cempra Pharmaceuticals
February 2013 - February 2017
Director, Pharmaceutical Development at
BIOCRYST IRELAND LIMITED
March 2012 - January 2013
Director, Formulations Development at
Banner Pharmacaps
July 2008 - January 2012
Senior Director, Pharmaceutics R&D at
Emisphere Technologies
October 1997 - July 2008
Post Doctoral Fellow at
The University of Iowa
December 1996 - October 1997
Shingai Majuru
Education
Western Connecticut State University, Mba
January 2006 - January 2009
University of Iowa, Ph.D.
January 1991 - January 1996
University of Iowa, Msc.
January 1991 - January 1994
University of Zimbabwe, M.Phil
January 1988 - January 1991
University of Zimbabwe, B.Pharm.(Hons.)
January 1985 - January 1987
Frequently Asked Questions about Shingai Majuru
What is Shingai Majuru email address?
Shingai Majuru's primary email address is **************@roivant.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Shingai Majuru work for?
Shingai Majuru is a Vice President, Head of CMC, Small Molecule Development at Roivant Sciences.
Where Shingai Majuru graduated from?
Shingai Majuru holds a degree in Business from Western Connecticut State University.
How can I directly contact Shingai Majuru?
To contact Shingai Majuru directly, you can use the email address **************@roivant.com. Complete contact information is available upon registration with Muraena.
Is Shingai Majuru an immigrant?
Yes, Shingai Majuru is an immigrant and currently based in United States
Who is Shingai Majuru?
Shingai Majuru is a seasoned pharmaceutical development executive with extensive experience in Chemistry, Manufacturing and Controls (CMC) within the biopharmaceutical sector. He currently serves as the Vice President and Head of CMC for Small Molecule Development at Roivant Sciences, where he leads strategic evaluations and global development strategies for in-licensing opportunities. His expertise encompasses a broad spectrum of CMC activities, including formulation development, regulatory documentation, and technology transfer. Shingai has a strong academic background, holding advanced degrees in Pharmaceutics and Business. He has contributed to numerous publications in the field, reflecting his commitment to advancing pharmaceutical sciences. His leadership style is characterized by a hands-on approach, fostering teamwork and innovation. Shingai's diverse experience spans both startup and corporate environments, allowing him to navigate complex challenges in drug development effectively.
Shingai`s contact details
**************@roivant.com
Colleagues
Chief Development Officer
Chief Communications Officer
Chief Financial Officer
Executive Director
VP, Special Projects, Office of CEO
Chief Executive Officer
VP, Research
Board Member
Senior Vice President, Investments
Vice President, Head of CMC, Biologics and Gene Therapies